Skip to content

TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2018-02-14

What TuHURA BIOSCIENCES, INC./NV reported in its quarterly report filed 2018-02-14 (fiscal Q2 2018): 21 published measures, 62 facts as tagged in accession 0001213900-18-001883.

This filing

Form
10-Q (quarterly report)
Filed
2018-02-14
Fiscal period
fiscal Q2 2018
Accession
0001213900-18-001883 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TuHURA BIOSCIENCES, INC./NV filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-12-3112,216,116USD
At 2017-06-307,911,021USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-12-312,232,542USD
At 2017-06-301,332,497USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-12-319,983,574USD
At 2017-06-306,578,524USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-12-3111,021,568USD
At 2017-06-306,586,014USD
At 2016-12-313,417,377USD
At 2016-06-306,157,264USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-3,161,598USD92
2017-07-01 to 2017-12-31-5,828,004USD184
2016-10-01 to 2016-12-31-1,321,973USD92
2016-07-01 to 2016-12-31-3,612,312USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-12-31-47,046,347USD
At 2017-06-30-41,118,433USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-10-01 to 2017-12-3122,559,234shares92
2017-07-01 to 2017-12-3118,882,259shares184
2016-10-01 to 2016-12-3111,424,485shares92
2016-07-01 to 2016-12-3111,363,237shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-10-01 to 2017-12-310.14USD/shares92
2017-07-01 to 2017-12-310.31USD/shares184
2016-10-01 to 2016-12-310.13USD/shares92
2016-07-01 to 2016-12-310.36USD/shares184

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-10-01 to 2017-12-31228,507USD92
2017-07-01 to 2017-12-31293,377USD184
2016-10-01 to 2016-12-31-75,202USD92
2016-07-01 to 2016-12-31-43,384USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-12-3112,187,036USD
At 2017-06-307,870,731USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-12-312,227,088USD
At 2017-06-301,304,360USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2017-12-3129,080USD
At 2017-06-3040,290USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-10-01 to 2017-12-313,153,824USD92
2017-07-01 to 2017-12-315,833,088USD184
2016-10-01 to 2016-12-311,692,196USD92
2016-07-01 to 2016-12-313,741,564USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-10-01 to 2017-12-312,141,945USD92
2017-07-01 to 2017-12-314,076,588USD184
2016-10-01 to 2016-12-311,120,910USD92
2016-07-01 to 2016-12-311,853,639USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-12-31932,761shares
At 2017-06-30982,761shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-12-3121,178USD
At 2017-06-3021,178USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2017-12-315,454USD
At 2016-12-31171,211USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-3,215,664USD92
2017-07-01 to 2017-12-31-5,923,736USD184
2016-10-01 to 2016-12-31-1,481,729USD92
2016-07-01 to 2016-12-31-4,079,366USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-10-01 to 2017-12-311,011,879USD92
2017-07-01 to 2017-12-311,756,500USD184
2016-10-01 to 2016-12-31571,286USD92
2016-07-01 to 2016-12-311,887,925USD184

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2017-07-01 to 2017-12-3111,210USD184
2016-07-01 to 2016-12-317,716USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-7,774USD92
2017-07-01 to 2017-12-315,084USD184
2016-10-01 to 2016-12-31370,223USD92
2016-07-01 to 2016-12-31129,252USD184

Inspect the source

Entity
TuHURA BIOSCIENCES, INC./NV / CIK 0001498382
Captured
2026-09-20T09:11:11.339Z
SEC response SHA-256
cbfb2cda3307f7af300be1fc56e9d85ca5186f16e46a189d675574c95ee74f5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001498382.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))